Vaxcyte Inc.

NASDAQ: PCVX · Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT

Vaxcyte Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-166.57M -140.72M -137.08M -103.12M -128.7M -95.02M -180.8M -92.66M -68.34M -60.46M -78.05M -57.92M -48.53M -38.99M -28.56M -26.61M -23.68M -21.22M
Depreciation & Amortization
4.99M 4.87M 4.79M 4.49M 3.48M 3.09M 2.95M 2.48M 2.4M 2.34M 2.3M 2.35M 2.17M 2.37M 1.21M 856K 868K 527K
Stock-Based Compensation
36.93M 30.61M 24.37M 21.27M 21.56M 17.63M 13.35M 13.22M 12.54M 9.65M 7.01M 6.65M 5.89M 4.1M 3.16M 2.94M 2.77M 1.86M
Other Working Capital
20.35M -20.35M -33.79M 20.91M 2.92M -7.97M 31.59M 33.29M 233K 4.98M -6.77M 11.96M -1.67M 6.33M -9.38M -7.55M -10.89M 3.29M
Other Non-Cash Items
-46.02M -11.53M -991K -12.56M -9.93M 7.15M 10.4M -14.57M -11.84M -5.99M 6.82M -238K 301K 422K 561K 461K 330K 151K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -12.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
49.52M -49.52M -2.48M 29.22M -7.79M -73.83M 38.06M 33.99M 2.5M 6.77M -3.3M 10.61M 1.04M 4.39M -27.45M -6.05M -8.97M 5.47M
Operating Cash Flow
-121.17M -166.27M -111.4M -60.71M -121.39M -159.12M -128.81M -57.55M -62.74M -47.69M -65.22M -38.55M -39.13M -27.7M -51.09M -28.41M -28.68M -13.21M
Capital Expenditures
19.52M -26.75M -30.03M -38.08M -45.37M -12.07M -57.07M -7.34M 2.14M -5.61M -1.15M -843K -938K -2.92M -1.38M -1.72M -2.21M -1.25M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -43.14K -29.62K 335.7K 442.49K 34.8K -35.55K -27.1K 7K 26K n/a n/a n/a
Purchase of Investments
-349.05M -314.49M -815.22M -1.23B -350.65M -687.7M -203.61M -209.67M -432.83M -483.78M -71.28M -17.59M -6.9M -6.97M -41.06M -66.75M -56.39M -172.15M
Sales Maturities Of Investments
436.55M 464.55M 288.07M 354.2M 309.22M 248.7M 246.75M 239.29M 97.13M 41.29M 36.48M 53.14M 34M 59.55M 42.5M 50M 38.06M n/a
Other Investing Acitivies
-29.27M n/a n/a n/a 6.39M -6.39M 43.14K 29.62K -335.7K -442.49K -34.8K 35.55K 27.1K 7K 26K -16.75M 38.06M -172.15M
Investing Cash Flow
77.74M 123.32M -557.17M -917.02M -80.41M -451.07M -13.93M 22.28M -333.56M -448.1M -35.95M 34.71M 26.16M 49.67M 82K -18.47M -20.53M -173.39M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 5.53M n/a n/a 5.58M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.52M 759K n/a 2.4M 3.83M 1.72M 2.73M -450K 1.69M -225K 3.02M 896K 874K 282K 1.97M 491K 956K 487K
Financial Cash Flow
2.52M 759K 4.91M 1.52B 110.37M 818.2M 2.73M 48.55M 546.97M 41.56M 656.63M 44.02M 49.88M 111.02M 8.75M 7.6M 956K 487K
Net Cash Flow
-40.11M -41.03M -662.31M 532.84M -92.84M 214.06M -147.68M 14.33M 150.58M -454.21M 556.26M 40.23M 36.43M 132.76M -43.06M -38.95M -47.94M -186.39M
Free Cash Flow
-101.65M -193.03M -141.43M -98.79M -166.77M -171.2M -185.88M -64.89M -60.6M -53.3M -66.37M -39.39M -40.06M -30.62M -52.48M -30.13M -30.89M -14.45M